Phase 1 Study to Compare the Safety, Pharmacokinetic Profiles of CJ-30056 and Lipitor/Glucophage XR
NCT02185066
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
42
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
Atorvastatin 20mg and Metformin XR 500mg (Reference)
DRUG:
CJ-30056 20/500mg (Test)
Sponsor
HK inno.N Corporation